Role of low dose capecitabine combined to irinotecan in advanced and metastatic gastric cancer. [electronic resource]
Producer: 20101230Description: 722-7 p. digitalISSN:- 1559-131X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Capecitabine
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Gastrectomy -- methods
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Palliative Care
- Radiotherapy, Adjuvant
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.